Fungal Secondary Metabolites: A Promising Source of Antineoplastic Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|6|3|222-228

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.6, Iss.3, 2010-08, pp. : 222-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment modifications of antineoplastic drugs in an oncology day-care unit

By Bremberg Eva R.   Rotstein Samuel   Eksborg Staffan  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 735-740

Informa Healthcare

Access to resources Recommend Favorite

Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)

By Alemón-Medina Radamés   Breña-Valle Matilde   Muñoz-Sánchez José   Gracia-Mora María   Ruiz-Azuara Lena  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 219-228

Springer Publishing Company

Access to resources Recommend Favorite

Antiinflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid

By                          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2574-2578

Spandidos Publications

Access to resources Recommend Favorite

Marine Macrolides, a Promising Source of Antitumor Compounds

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 2, 2009-02 ,pp. : 122-137

Bentham Science Publishers

Access to resources Recommend Favorite

Eribulin mesylate: a promising new antineoplastic agent for locally advanced or metastatic breast cancer

By Cortes Javier   Lorca Rebeca  

Future Oncology, Vol. 7, Iss. 3, 2011-03 ,pp. : 355-364

Future Medicine

Access to resources Recommend Favorite